Praxis Precision Medicine (NASDAQ:PRAX) just reported results for the first quarter of 2024.
- Praxis Precision Medicine reported earnings per share of -$2.84. This was below the analyst estimate for EPS of -$2.08.
- The company reported revenue of $431,000.
- This was 73.40% worse than the analyst estimate for revenue of $1.62 million.